Lindbrook Capital LLC Acquires 2,351 Shares of CVS Health Co. (NYSE:CVS)

Lindbrook Capital LLC raised its holdings in shares of CVS Health Co. (NYSE:CVS) by 35.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 9,013 shares of the pharmacy operator’s stock after acquiring an additional 2,351 shares during the period. Lindbrook Capital LLC’s holdings in CVS Health were worth $712,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bryn Mawr Capital Management LLC raised its position in shares of CVS Health by 74.0% during the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after acquiring an additional 18,385 shares during the last quarter. Value Partners Investments Inc. increased its position in shares of CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after buying an additional 207,702 shares in the last quarter. Sonora Investment Management Group LLC increased its position in shares of CVS Health by 1.6% in the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after buying an additional 774 shares in the last quarter. Checchi Capital Advisers LLC increased its position in shares of CVS Health by 2.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after buying an additional 233 shares in the last quarter. Finally, Personal CFO Solutions LLC increased its position in shares of CVS Health by 2.6% in the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock valued at $1,351,000 after buying an additional 491 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.24% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent analyst reports. SVB Leerink initiated coverage on shares of CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a research report on Wednesday, April 10th. Royal Bank of Canada reduced their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Stock Performance

Shares of CVS stock traded up $1.02 on Friday, reaching $69.75. The stock had a trading volume of 7,809,721 shares, compared to its average volume of 8,823,763. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm’s 50-day moving average is $75.29 and its two-hundred day moving average is $73.74. The firm has a market capitalization of $87.92 billion, a price-to-earnings ratio of 10.80, a P/E/G ratio of 0.92 and a beta of 0.52. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. CVS Health’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.99 EPS. On average, research analysts expect that CVS Health Co. will post 8.32 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 3.81%. CVS Health’s dividend payout ratio is currently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.